ContractExecutive Employment Agreement • March 1st, 2021 • Viatris Inc • Pharmaceutical preparations • New York
This Executive Employment Agreement (this “Agreement”) is entered into on November 20, 2020, by and between Viatris Inc. (the “Company”) and Robert J. Coury (the “Executive”).
VIATRIS INC. RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit • March 1st, 2021 • Viatris Inc • Pharmaceutical preparations • Pennsylvania
THIS RESTRICTED STOCK UNIT AWARD AGREEMENT (this “Agreement”), dated as of [________] (the “Date of Grant”), is made by and between Viatris Inc., a Delaware corporation (the “Company”), and [_______] (the “Participant”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the EMA (as defined below).
RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • March 1st, 2021 • Viatris Inc • Pharmaceutical preparations • Pennsylvania
THIS RESTRICTED STOCK UNIT AWARD AGREEMENT (this “Agreement”), dated as of November 20, 2020 (the “Date of Grant”), is made by and between Viatris Inc., a Delaware corporation (the “Company”), and [______] (the “Participant”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the EMA (as defined below).
Pfizer Inc. Letterhead]Viatris Inc • March 1st, 2021 • Pharmaceutical preparations
As you know, Pfizer Inc. (“Pfizer”), Upjohn Inc. (“Upjohn”) and Mylan N.V. (“Mylan”), among other parties, entered into a Business Combination Agreement, dated July 29, 2019, to combine Upjohn and Mylan (the “Combination”) to form Viatris Inc. (“Viatris”). You are or will be employed by an entity that will be conveyed to Viatris in connection with the Combination and will, therefore, become a colleague of Viatris upon the Close Date.
Re: Retention AgreementViatris Inc • March 1st, 2021 • Pharmaceutical preparations • Pennsylvania
As you know, Mylan N.V. (“Mylan”) and Upjohn Inc. (“Upjohn”) consummated the combination of Mylan and Upjohn pursuant to the Business Combination Agreement between Pfizer Inc., Upjohn, Mylan and the other parties thereto to create Viatris Inc. (the “Company”), a new champion for global health, on November 16, 2020. In recognition of your efforts in connection with the consummation of the combination (the “Closing”), and in order to incentivize you to remain employed with the Company and its affiliates, the Company hereby grants you the following retention bonus opportunity.
Viatris Inc. Value Creation Incentive Award Performance-Based Restricted Stock Unit Award AgreementRestricted Stock Unit Award Agreement • March 1st, 2021 • Viatris Inc • Pharmaceutical preparations • Pennsylvania
Viatris Inc. (the “Company”) hereby grants to ROBERT J. COURY (the “Participant”), effective as of November 23, 2020 (the “Grant Date”), the performance-based restricted stock unit award (the “Performance RSUs”) as set forth in this Award Agreement. The Performance RSUs are subject to the terms and conditions set forth in this Award Agreement and in the Company’s 2020 Stock Incentive Plan (the “Plan”). In the event of any inconsistency between the terms of this Award Agreement and the terms of the Plan, the terms of the Plan shall govern except to the extent specifically set forth herein. Capitalized terms used but not defined in this Award Agreement (including Exhibit A hereto) shall have the meanings ascribed to them in the Plan or the Participant’s employment agreement with the Company dated as of November 20, 2020 (the “Employment Agreement”), as applicable. Notwithstanding the foregoing, the Performance RSUs shall be subject to the terms of the Employment Agreement.
Re: Retention AgreementViatris Inc • March 1st, 2021 • Pharmaceutical preparations • Pennsylvania
As you know, Mylan N.V. (“Mylan”) and Upjohn Inc. (“Upjohn”) consummated the combination of Mylan and Upjohn pursuant to the Business Combination Agreement between Pfizer Inc., Upjohn, Mylan and the other parties thereto to create Viatris Inc. (the “Company”), a new champion for global health, on November 16, 2020. In recognition of your efforts in connection with the consummation of the combination (the “Closing”), and in order to incentivize you to remain employed with the Company and its affiliates, the Company hereby grants you the following retention bonus opportunity.
AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 1st, 2021 • Viatris Inc • Pharmaceutical preparations • London
THIS AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT (this “Agreement”), is made as of November 5, 2020, by and between Mylan Ireland Limited, a company incorporated in Ireland and Aspen Global Incorporated, a company incorporated in Mauritius (registered number 078138) (collectively, the “Parties”).
FORM OF INDEMNIFICATION AGREEMENTForm of Indemnification Agreement • March 1st, 2021 • Viatris Inc • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of [ ], between Viatris Inc., a Delaware corporation (the “Company”), and [ ] (“Indemnitee”).
